Brain (and spinal cord) tumours
Results
Phase 1
This trial looked pelareorep (Reolysin), a treatment made from a virus called reovirus. It was for a type of brain tumour called glioblastoma.
The trial was supported by Cancer Research UK. It was open for people to join between 2017 and 2019. The team presented the results at a conference in 2020.
Recruitment start: 19 September 2017
Recruitment end: 31 March 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Susan Short
Cancer Research UK
The Brain Tumour Charity
Oncolytics Biotech Inc
Yorkshire Cancer Research
University of Leeds
This is Cancer Research UK trial number CRUKD/16/007
Last reviewed: 23 November 2021
CRUK internal database number: 14314
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
